Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
immunotherapy
5
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
pfizer
5
×
raleigh-durham blog main
raleigh-durham top stories
roche
5
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
cancer
merck
bristol-myers squibb
novartis
spark therapeutics
abbvie
celgene
cell therapy
clinical trials
What
annual
conference
medical
society
ash
bio
cancer
clinical
drug
esmo
european
oncology
patients
roundup
today
acquisitions
advantages
albert
american
bar
barcelona
biggest
blood
borne
bourla
breast
brings
cancer's
cancers
ceo
company
crispr
data
december's
diego
expect
future
gamble
gathering
guide
Language
unset
unknown
Current search:
roche
×
pfizer
×
immunotherapy
×
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
ESMO ’18: Precision Meds, Breast, Lung, and More from the Cancer Front